Kaineng Health announced that it intends to use its own or self-raised funds to repurchase the company's shares through centralized bidding transactions. The total capital is not less than 50 million yuan and no more than 100 million yuan, and the repurchase price is not more than 6.5 yuan/share. The repurchase of shares is intended to be used for equity incentives or employee stock ownership plans. The implementation period is 6 months from the date the board of directors reviews and approves the plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.